Clinical Practice Guidelines
2.0.0 - STU2 International flag

Clinical Practice Guidelines, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cqf-recommendations/ and changes regularly. See the Directory of published versions

PlanDefinition: CKD VA Recommendations Plan Definition (Experimental)

Official URL: http://hl7.org/fhir/uv/cpg/PlanDefinition/va-ckd-recommendations Version: 2.0.0
Active as of 2026-04-29 Computable Name: VACKDRecommendations
Other Identifiers: VA_CKD_Recommendations (use: official, ), OID:2.16.840.1.113883.4.642.40.48.34.38

Usage: Clinical Focus: Chronic kidney disease (disorder)

VA CKD Recommendations

Metadata
Version 2.0.0
Identifier VA_CKD_Recommendations
Identifier urn:oid:2.16.840.1.113883.4.642.40.48.34.38
Experimental true
Use Context Clinical Focus = Chronic kidney disease (disorder)
Jurisdiction World
Topic Treatment
Steward (Publisher) HL7 International / Clinical Decision Support
Steward Contact HL7 International / Clinical Decision Support
Description

VA CKD Recommendations
Type ECA Rule
PlanDefinition Action
Id 001
Strength of Recommendation Weak
Title CKD Protein Diet
Description In patients with stage 3 and 4 CKD, we suggest a protein diet of 0.6 to 0.8 g/kg/day as it may slow the decline in glomerular filtration rate (GFR) and progression to end-stage renal disease (ESRD).
Condition ​ Kind: Applicability
Logic Definition: Has CKD stage 3 or 4
Generated using version 0.5.4 of the sample-content-ig Liquid templates